Eric L Eisenstein
Overview
Explore the profile of Eric L Eisenstein including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
114
Citations
1501
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hamidi M, Eisenstein E, Garza M, Morales K, Edwards E, Rocca M, et al.
J Clin Transl Sci
. 2024 Dec;
8(1):e101.
PMID: 39676880
Introduction: The value of Source Data Verification (SDV) has been a common theme in the applied Clinical Translational Science literature. Yet, few published assessments of SDV quality exist even though...
2.
Cramer A, King L, Buckley M, Casteleyn P, Ennis C, Hamidi M, et al.
Contemp Clin Trials Commun
. 2024 Dec;
42():101391.
PMID: 39651464
Background: eSource software that transfers patient electronic health record data into a clinical trial electronic case report form holds promise for increasing data quality while reducing data collection, monitoring and...
3.
Thompson A, Fleischmann K, Smilowitz N, de las Fuentes L, Mukherjee D, Aggarwal N, et al.
J Am Coll Cardiol
. 2024 Sep;
84(19):1869-1969.
PMID: 39320289
Aim: The "2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery" provides recommendations to guide clinicians in the perioperative cardiovascular evaluation and management of adult patients undergoing noncardiac surgery....
4.
Thompson A, Fleischmann K, Smilowitz N, de las Fuentes L, Mukherjee D, Aggarwal N, et al.
Circulation
. 2024 Sep;
150(19):e351-e442.
PMID: 39316661
Aim: The "2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery" provides recommendations to guide clinicians in the perioperative cardiovascular evaluation and management of adult patients undergoing noncardiac surgery....
5.
Garza M, Spencer C, Hamidi M, Liss M, Bikkanuri M, Syed M, et al.
Stud Health Technol Inform
. 2024 Aug;
316:1368-1372.
PMID: 39176635
While pilots and production use of software based on the Health Level Seven (HL7®) Fast Healthcare Interoperability Resources (FHIR®) standard are increasing in clinical research, we lack consistent evaluative data...
6.
Cramer A, King L, Buckley M, Casteleyn P, Ennis C, Hamidi M, et al.
Res Sq
. 2024 Jun;
PMID: 38826202
Background: eSource software that copies patient electronic health record data into a clinical trial electronic case report form holds promise for increasing data quality while reducing data collection, monitoring and...
7.
Kittipibul V, Mentz R, Clare R, Wojdyla D, Anstrom K, Eisenstein E, et al.
Eur J Heart Fail
. 2024 May;
26(7):1518-1523.
PMID: 38745502
Aim: The TRANSFORM-HF trial demonstrated no significant outcome differences between torsemide and furosemide following hospitalization for heart failure (HF), but may have been impacted by non-adherence to the randomized diuretic....
8.
Natesan D, Eisenstein E, Thomas S, Eclov N, Dalal N, Stephens S, et al.
NEJM AI
. 2024 Apr;
1(4).
PMID: 38586278
Background: Machine learning (ML) may cost-effectively direct health care by identifying patients most likely to benefit from preventative interventions to avoid negative and expensive outcomes. System for High-Intensity Evaluation During...
9.
Martens P, Greene S, Mentz R, Li S, Wojdyla D, Kapelios C, et al.
Eur J Heart Fail
. 2024 Apr;
26(5):1242-1250.
PMID: 38558520
Aim: Among patients discharged after hospitalization for heart failure (HF), a strategy of torsemide versus furosemide showed no difference in all-cause mortality or hospitalization. Clinicians have traditionally favoured torsemide in...
10.
Kapelios C, Greene S, Mentz R, Ikeaba U, Wojdyla D, Anstrom K, et al.
Circ Heart Fail
. 2024 Mar;
17(3):e011246.
PMID: 38436075
Background: The TRANSFORM-HF trial (Torsemide Comparison With Furosemide for Management of Heart Failure) found no significant difference in all-cause mortality or hospitalization among patients randomized to a strategy of torsemide...